A Phase I Multicenter Study of E1A Gene Therapy for Patients with Metastatic Breast Cancer and Epithelial Ovarian Cancer That Overexpresses HER-2/<i>neu</i>or Epithelial Ovarian Cancer. M.D. Anderson Cancer Center, Houston, Texas
One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage PlusPublished in last 50 years